Inflammatory Bowel Disease Therapies and Gut Function in a Colitis Mouse Model

Table 1

Population, sex, and group description of IL-10^−/− mice on a C57BL/6 background.

Group no.	Group description	Total number of mice
1	Noninfeced control group; no infection and no treatment (66.7% female)	9 (killed time 0)
Treatments		week 2	week 4
2	Infected control group; treatment: sterilized water (𝑛=12; 58.3% female)	6	6
3	^1HC group; treatment: HC (𝑛=12; 41.7% female)	6	^26
4	^3EEN group; treatment: ^4PF (𝑛=13; 46.2% female)	8	5
5	^5MNZ group; treatment: MNZ (𝑛=13; 46.2% female)	7	6
6	EEN + MNZ group; treatment: a combination of PF and MNZ (𝑛=12. 50% female)	6	6

¹Hydrocortisone; ²mice in this group were euthanized at week 3 because of severe diarrhea, dehydration, and weight loss (their indexes were compared to those of other groups at week 4 throughout this study); ³exclusive enteral nutrition; ⁴polymeric formula; ⁵metronidazole.